Article
A HSV1 mutant leads to an attenuated phenotype and induces immunity with a protective effect.
PLoS pathogens - 1 Aug 2020
Xu Xingli, Feng Xiao, Wang Lichun, Yi Ting, Zheng Lichun, Jiang Guorun, Fan Shengtao, Liao Yun, Feng Min, Zhang Ying, Li Dandan, Li Qihan
Abstract excerpt
Herpes simplex virus type 1 (HSV1) is a complicated structural agent with a sophisticated transcription process and a high infection rate. A vaccine against HSV1 is urgently needed. As multiple viral-encoded proteins, including structural and nonstructural proteins, contribute to immune response stimulation, an attenuated or deficient HSV1 vaccine may be relatively reliable. Advances in genomic modification...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
